We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
-0.78%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$550M
AUM Growth
+$157M
(+40%)
Cap. Flow
+$181M
Cap. Flow
% of AUM
32.82%
Top 10 Holdings %
Top 10 Hldgs %
9.69%
Holding
1,013
New
425
Increased
119
Reduced
70
Closed
399
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$5.22M |
| 2 |
Agilent Technologies
A
|
+$4.93M |
| 3 |
Microsoft
MSFT
|
+$4.87M |
| 4 |
Thomson Reuters
TRI
|
+$4.55M |
| 5 |
NextEra Energy
NEE
|
+$4.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$12.2M |
| 2 |
Moderna
MRNA
|
+$8.97M |
| 3 |
Apple
AAPL
|
+$5.54M |
| 4 |
Qualcomm
QCOM
|
+$4.48M |
| 5 |
UnitedHealth
UNH
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17% |
| 2 | Healthcare | 13.82% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Financials | 11.56% |
| 5 | Industrials | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CKPT
676
DELISTED
Checkpoint Therapeutics
CKPT
| – | – |
-1,197
| Closed | -$35K |
|
677
Cleveland-Cliffs
CLF
$6.99B
| – | – |
-59,446
| Closed | -$1.28M |
|
678
Global X Cloud Computing ETF
CLOU
$227M
| – | – |
-9,152
| Closed | -$261K |
|
679
Clorox
CLX
$11.8B
| – | – |
-3,092
| Closed | -$556K |
|
680
Canadian Imperial Bank of Commerce
CM
$108B
| – | – |
-7,278
| Closed | -$414K |
|
681
CME Group
CME
$92.3B
| – | – |
-2,772
| Closed | -$590K |
|
682
Compass Minerals
CMP
$1.25B
| – | – |
-4,001
| Closed | -$237K |
|
683
Capital One
COF
$127B
| – | – |
-8,444
| Closed | -$1.31M |
|
684
Columbia Banking Systems
COLB
$8.74B
| – | – |
-5,253
| Closed | -$203K |
|
685
Columbia Sportswear
COLM
$3.25B
| – | – |
-3,289
| Closed | -$324K |
|
686
Cencora
COR
$60.5B
| – | – |
-5,249
| Closed | -$601K |
|
687
Coty
COTY
$2.39B
| – | – |
-50,461
| Closed | -$471K |
|
688
Coupang
CPNG
$28.6B
| – | – |
-9,275
| Closed | -$388K |
|
689
Capri Holdings
CPRI
$1.82B
| – | – |
-10,171
| Closed | -$582K |
|
690
Corbus Pharmaceuticals
CRBP
$168M
| – | – |
-682
| Closed | -$37K |
|
691
Cerence
CRNC
$375M
| – | – |
-4,059
| Closed | -$433K |
|
692
CRISPR Therapeutics
CRSP
$4.6B
| – | – |
-3,716
| Closed | -$602K |
|
693
CoStar Group
CSGP
$11.9B
| – | – |
-11,001
| Closed | -$911K |
|
694
Cintas
CTAS
$84.4B
| – | – |
-18,196
| Closed | -$1.74M |
|
695
Commault Systems
CVLT
$6.19B
| – | – |
-2,781
| Closed | -$217K |
|
696
Carvana
CVNA
$45.9B
| – | – |
-15,420
| Closed | -$931K |
|
697
CVS Health
CVS
$137B
| – | – |
-18,469
| Closed | -$1.54M |
|
698
Crane NXT
CXT
$3.12B
| – | – |
-6,743
| Closed | -$216K |
|
699
Dominion Energy
D
$61.8B
| – | – |
-11,457
| Closed | -$843K |
|
700
Deutsche Bank
DB
$67.9B
| – | – |
-20,984
| Closed | -$274K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q3 2021 Portfolio in Review
As of Q3 2021, Y-Intercept (HK) held 1,013 positions worth $550M, up 40% from $393M the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Y-Intercept (HK) deployed $181M of net new capital in Q3 2021, opening 425 new positions and adding to 119 existing holdings. Its largest new stake was Nike: 32,025 shares worth $4.65M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $5.54M trimmed.
- Y-Intercept (HK)'s largest Q3 2021 buy was Nike: 32,025 shares worth $4.65M.
- Y-Intercept (HK) added most to Microsoft in Q3 2021, an estimated $4.87M increase.
- Y-Intercept (HK)'s biggest Q3 2021 reduction was Apple, cutting an estimated $5.54M.
- Y-Intercept (HK) fully exited Linde in Q3 2021, selling an estimated $12.2M.
- Y-Intercept (HK)'s ten largest holdings make up 9.7% of its $550M portfolio in Q3 2021.
- Y-Intercept (HK) opened 425 new positions and closed 399 in Q3 2021.
- Y-Intercept (HK)'s portfolio value rose 40% quarter-over-quarter to $550M.
Based on Y-Intercept (HK)'s 13F filing for Q3 2021, filed 15 Nov 2021.